Overview: The premarket notification [510(k)] is the most common pathway to market for medical devices including in vitro diagnostic medical devices.
Pursuant to the section [510(k)] of the Federal Food, Drug, and Cosmetic Act (FD&C Act or the Act), the 510(k) premarket submission is made to FDA to demonstrate that the subject device (to be marketed) is substantially equivalent (as least as safe and effective) to a legally marketed device (predicate device). In other words, 510(k)s must demonstrate that a proposed product is substantially equivalent to another, legally marketed medical device that is also lower-risk and is not subject to premarket approval (PMA).
Thus, it is a must to adequately prepare your next 510(k) to get it successfully cleared in a timely manner, saving significant amount of your unnecessary time, energy, and other resources.
This webinar will discuss how to prepare a 510(k) quality submission including guidelines for the format and content of the 510(k). Please join and make sure you have all the bases and requirements for successful 510(k) submission package covered.
Why Should You Attend: It is crucial that device manufacturers understand 510(k) pitfalls and prepare against the pitfalls. Device firms should also consider the impact on your budget.
Thus, an adequate preparation of your next 510(k) to obtain successful clearance of your 510(k)s. This webinar will discuss how to prepare a 510(k) quality submission including guidelines for the format and content of the 510(k). Please join and make sure you have all the bases and requirements for the 510(k) submission package covered.
Areas Covered in the Session:
Applicable statute(s) and regulations
Definitions and device classification
When and who are required to submit a 510(k)
How to identify a suitable predicate device(s), if any
How to demonstrate substantial equivalence
Recent changes in the 510(k) program
Decision points during 510(k) review
Differences in contents of 510(k)s based on products
How to identify regulatory requirements relevant and applicable to the product(s)
How to address the relevant and applicable regulatory requirements
How to present your performance data and clinical data in a succinct, comprehensive manner
How to increase 510(k) submission quality for a product
How to respond to FDA’s request of additional information
How to resolve different opinions between the submitter and FDA reviewer(s)
Who Will Benefit:
Regulatory Affairs Managers, Directors and VPs
Clinical Affairs Managers, Directors and VPs
Quality Managers, Directors and VPs
Quality Managers, Directors and VPs
Compliance Managers and Directors
Sales and Marketing Managers, Directors, and VPs
Complaint Handling and Risk Management Managers and Directors